Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text

Medicine, Maternal Health, Obstetrics +17

Circulating Angiogenic Factors and the Risk of Preeclampsia

Richard J. Levine, Cong Qian, Lucinda J. England et al. · New England Journal of Medicine · 2004 · 3.6K citations · Full text

Public Health, Maternal Health, Obstetrics +11

Circulating angiogenic factors and the risk of preeclampsia*

Obstetrics and Gynecology · 2004 · 2.6K citations

Medicine, Gynecology, Obstetrics +14

Soluble endoglin contributes to the pathogenesis of preeclampsia

Shivalingappa Venkatesha, Mourad Toporsian, Chun Sing Lam et al. · Nature Medicine · 2006 · 1.8K citations

Public Health, Maternal Health, Obstetrics +10

Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia

Richard J. Levine, Chun Sing Lam, Cong Qian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Public Health, Maternal Health, Obstetrics +14